Dr. Reddy's Laboratories RDY will announce results for the Fourth Quarter & Full Year ended March 31, 2012 on Friday, May 11, 2012 after the Board Meeting. The results will be available on the Company's website www.drreddys.com.
Summary of Events
Event |
Date and Time (IST) |
Medium |
||||
Release of financial results | May 11, after the Board Meeting | Email, Media, Company website, Businesswire | ||||
Earnings Call | May 11, 6.30 PM IST / 9:00 AM EST |
Hosted by the Company
(Details below) |
||||
Webcast of Earnings Call | May 11, 6.30 PM IST / 9.00 AM EST through May 16, 2012 |
URL available on Company's website, |
||||
Transcripts of the Earnings call | Will be available on the Company's website |
URL available on Company's website, |
||||
Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company's financial performance.
Conference Dial-In Numbers |
|||
Primary Number: | +91 22 6629 0356 | ||
Secondary Number: | +91 22 3065 0136 | ||
The numbers listed above are universally accessible from all networks and all countries. | |||
Local Access Number: |
6000 1221 |
||
International Toll Free Number: |
USA: 1 866 746 2133
UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 |
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through May 16, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the Company's website.
About Dr. Reddy's
Established in 1984, Dr. Reddy's Laboratories RDY is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Our products are marketed globally, with a focus on India, US, UK, Germany and Russia.
Website: www.drreddys.com
Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye,
+91 40 66834297
kedaru@drreddys.com
or
Raghavender
R, +91 40 49002135
raghavenderr@drreddys.com
or
Saunak
Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan
Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.